1. Antiviral
    To establish the fact that MAC/98alive™ has antiviral activity, the following encapsulated strains were studied and killed by MAC/98alive™:

    • Corona Virus (SARS group)
    • Herpes Simplex 1 & 2
    • Avian A type H3N2 (Swine flu) – San Yet-San Medical University, China (2009)
    • Avian A type H5N7 (Wild strain -so called Spanish flu that killed 50 million people) (2009)
    • Avian A type H5N1 (current Bird flu Vietnam strain) (2009)
    • Dengue Fever (all 4 strains) University of Indonesia Jakarta (2007)

    In all cases MAC/ 98alive™ killed these strains in vitro and for dengue patients in vivo.

  2. Antibacterial
    This work was carried out by Professor Thomas Riley in 2005 at the University of Western Australia Queen Elizabeth II Centre, Biotest Laboratories (TGA & NATA Listed Laboratory) and Queensland pathology Department, Brisbane.

    Food Pathogens Melaleuca Oil 98Alive™ % Efficacy Increase
    Staphylococcus aureus 10,000 ppm 50 ppm 200
    Escherichia coli 4,000 ppm 100 ppm 40
    Klebsiella pneumoniae 2,500 ppm 100 ppm 40
    Bacillius cereus No kill 100 ppm
    Proteus vulgaris 4,000 ppm 50 ppm 80
    Pseudomonas aeruginosa 8,000 ppm 900 ppm 9

    The bacteria challenge level was 107 – (10,000,000 cells per ml)

    In all, 53 other strains were tested against 98alive. They all proved increased efficacy.

    Additional studies conducted in 2005/2006 at the Queensland Government pathology Department’s Library of Antibiotic Resistant Strains Project (Australia). Results below:

    Table X

    Antibiotic resistant strain Number of strains 98Alive™ kill level
    MRSA 20 wild strains 150 ppm
    Acinetobacter baumannii 14 wild strains 150 ppm
    Escherichia coli 10 wild strains 150 ppm
    Klebsiella pneumonia 10 wild strains 150 ppm
    Enterobacter cloacae 6 wild strains 150 ppm
    Klebsiella oxytoca 2 wild strains 150 ppm
    E faecium Van A 6 wild strains 150 ppm
    E faecalis Van B 14 wild strains 150 ppm